Elephant man disease wikipedia

Proteus syndrome photos

    Joseph Carey Merrick (5 August – 11 April ) was an English artist known for his severe physical deformities. He was first exhibited at a freak show under the stage name "The Elephant Man", and then went to live at the London Hospital, in Whitechapel, after meeting Sir Frederick Treves, subsequently becoming well known in London society.

Elephant man death

In a article in the British Medical Journal, Michael Cohen and J.A.R. Tibbles proposed the idea that Joseph Merrick (an Englishman known as the "Elephant Man") had Proteus syndrome. However, the exact condition that Joseph Merrick had is still not known with certainty.


Proteus syndrome face

Elephantiasis, often incorrectly called elephantitis, is the enlargement and hardening of limbs or body parts due to tissue swelling (edema). [1][2] It is characterised by edema, hypertrophy, and fibrosis of skin and subcutaneous tissues, due to obstruction of lymphatic vessels (lymphedema). [2]. It may affect the genitalia. [2].

  • Proteus syndrome is a rare genetic disorder that can cause tissue overgrowth involving all three embryonic lineages.
  • Joseph Carey Merrick (5 August 1862 – 11 April 1890) was an English artist known for his severe physical deformities. He was first exhibited at a freak show under the stage name "The Elephant Man", and then went to live at the London Hospital, in Whitechapel, after meeting Sir Frederick Treves, subsequently becoming well known in London society.
  • The exact cause of Merrick's deformities is unclear, but in 1986 it was conjectured that he had Proteus syndrome.
  • As attenuated forms of the disease may exist, there could be many people with Proteus syndrome who remain undiagnosed. Those most readily diagnosed are also the most severely disfigured. The syndrome is named after the Greek sea god Proteus, who could change his shape. The condition appears to have been first described in the American medical.
  • elephant man disease wikipedia


    1. Is the elephant man: a true story

    Proteus syndrome is one of the rarest genetic conditions in the world. The syndrome causes abnormal overgrowth in certain parts of the body. It is commonly called the Elephant Man disease.
  • Who discovered proteus syndrome

  • Proteus syndrome - Wikipedia Proteus syndrome is one of the rarest genetic conditions in the world. The syndrome causes abnormal overgrowth in certain parts of the body. It is commonly called the Elephant Man disease. ‌This.
  • Sir Frederick Treves, 1st Baronet - Wikipedia Elephantiasis, often incorrectly called elephantitis, is the enlargement and hardening of limbs or body parts due to tissue swelling (). [1] [2] It is characterised by edema, hypertrophy, and fibrosis of skin and subcutaneous tissues, due to obstruction of lymphatic vessels (). [2].
  • Joseph Merrick - Simple English Wikipedia, the free encyclopedia Proteus syndrome, sometimes called Elephant Man’s disease, is a rare congenital disorder. We’ll explain what causes it, and how it’s diagnosed.


  • The elephant man real picture

    Joseph Carey Merrick (5 August – 11 April ) was an Englishman. His face and body were deformed because of an illness. To earn food, he was shown at freak shows. He was called the Elephant Man. He then became famous after he went to live at the London Hospital. Some people who wrote about him wrongly thought he was called John Merrick.
  • The elephant man real picture


  • Proteus syndrome

    The syndrome became widely recognised after the release of the movie “The Elephant Man”, a screenplay depicting the life of Joseph Merrick who was thought to have neurofibromatosis, but is now believed to actually have had severe Proteus syndrome.

    Who discovered proteus syndrome

  • Neurofibromatosis; Back of an elderly woman with neurofibromatosis type 1: Specialty: Neurosurgery, neurology, Neuro-oncology: Symptoms: Small lumps within the skin, scoliosis, hearing loss, vision loss [1].

  • Elephant syndrome face

    Theralizumab (also known as TGN, CDSuperMAB, and TAB08) is an immunomodulatory drug developed by immunologist Thomas Hünig of the University of Wü was withdrawn from development after inducing severe inflammatory reactions as well as chronic organ failure in the first-in-human study by Parexel in London in March [1].